BioCorRx (BICX) Net Cash Flow Growth (3y) (2013 - 2026)
BioCorRx (BICX) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 54.67% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | -88.93% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | -41.97% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 60.86% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | -70.77% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 38.26% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | -21.23% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | -38.79% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | - |
| 10 | BioCorRx | 1.49 Mn | 1.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.71% |
| Dec 31, 2025 | -214.69% |
| Sep 30, 2025 | 78.30% |
| Jun 30, 2025 | 41.99% |
| Mar 31, 2025 | -35.75% |
| Dec 31, 2024 | 28.73% |
| Sep 30, 2024 | -29.97% |
| Jun 30, 2024 | 57.49% |
| Mar 31, 2024 | -69.92% |
| Dec 31, 2023 | 35.77% |
| Sep 30, 2023 | 57.37% |
| Jun 30, 2023 | 76.73% |
| Mar 31, 2023 | 30.06% |
| Dec 31, 2022 | 26.11% |
| Sep 30, 2022 | 66.03% |
| Jun 30, 2022 | -26.44% |
| Mar 31, 2022 | 35.50% |
| Dec 31, 2021 | -176.66% |
| Sep 30, 2021 | 28.62% |
| Jun 30, 2021 | -58.68% |